HEALTH● LOWSep 9 · Sep 9, 2026, 9:08 PM
Experimental AstraZeneca Drug Reduces COPD Flare-Ups in Late-Stage Trials
Human Progress · global
“A drug being developed by AstraZeneca significantly reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, researchers reported on Tuesday at the medical meeting in Barcelona. Patients receiving Astra's tozorakimab during the year-long studies experienced about 29% to 34% fewer moderate-to-severe COPD exacerbations than those receiving a placebo, the researchers reported. Overall rates […] The post AstraZeneca Drug Reduces COPD Flare-Ups in Trials appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR NewsHEALTH2h agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH2h ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH2h agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."Clarín